*  Brain Manganese Deposition in High Risk Neonates - Full Text View - ClinicalTrials.gov
Brain Manganese Deposition in High Risk Neonates. The safety and scientific validity of this study is the responsibility of the ... Excessive exposure to manganese (Mn) results in Mn deposition in the brain causing adverse neurological effects. Sick infants ... Manganese (Mn) is an essential metal needed for normal growth and development. Excessive environmental or dietary exposure ... Neuroimaging identifies increased manganese deposition in infants receiving parenteral nutrition. Am J Clin Nutr. 2015 Dec;102( ...
https://clinicaltrials.gov/ct2/show/NCT00392977
*  Neurodevelopment and Neuroimaging in Parenterally-fed Infants and Young Children - Full Text View - ClinicalTrials.gov
Manganese (Mn) is an essential metal required for normal growth and development. However, exposure to high Mn levels can be ... Neuroimaging identifies increased manganese deposition in infants receiving parenteral nutrition. Am J Clin Nutr. 2015 Dec;102( ... Aschner JL, Aschner M. Nutritional aspects of manganese homeostasis. Mol Aspects Med. 2005 Aug-Oct;26(4-5):353-62. Review. ... Fitsanakis VA, Piccola G, Marreilha dos Santos AP, Aschner JL, Aschner M. Putative proteins involved in manganese transport ...
https://clinicaltrials.gov/ct2/show/NCT00392730
*  Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer - Full Text View - ClinicalTrials.gov
In this Phase 1 study, the investigators will conduct a dose-escalation study of the combination of BMX-001 with standard radiation therapy (RT) and concurrent 5-fluorouracil (5FU)/mitomycin in newly diagnosed Anal Squamous Cell Carcinoma (ASCC) patients. The dose escalation will be a Rolling-6 design, which is an efficient phase I trial design, to determine the maximum tolerated dose (MTD) of BMX-001 in combination with concurrent 5FU/mitomycin and RT. Subjects will be administered BMX-001 subcutaneously first as a loading dose at least 2 hours before the initiation of chemoradiation and then at a maintenance dose (50% of the loading dose) twice a week for up to seven weeks.. Based on Rolling-6 design (1), cohorts of 2-6 patients are concurrently enrolled onto a dose level, beginning with 0.1 mg/kg, until the maximum tolerated dose (MTD) is defined. The average number of subjects required for this Phase 1 is estimated to be 20, and the maximum estimated to be 24. The maximum tolerated dose ...
https://www.clinicaltrials.gov/ct2/show/NCT03386500?map_cntry=US&rank=49
*  Search of: 'Optic neuritis' - List Results - ClinicalTrials.gov
Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis. *Multiple Sclerosis ...
https://clinicaltrials.gov/ct2/results?cond=%22Optic+neuritis%22&show_down=Y
*  Search of: parkinson's disease[ALL-FIELDS] - List Results - ClinicalTrials.gov
determination by atomic absorption spectroscopy of the concentration of manganese, copper and iron ...
https://clinicaltrials.gov/ct2/results?term=parkinson
*  Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty - Full Text View - ClinicalTrials.gov
... manganese, iron, nickel), F562 cobalt chromium alloy (cobalt, chromium, nickel), 316L surgical stainless steel (iron, chromium ... and manganese), or components of the platinum chromium alloy stent. ...
https://clinicaltrials.gov/ct2/show/NCT01121224?term=cardiac+rehabilitation&recr=Open&fund=01&rank=8
*  The Effectiveness of Micronutrient Supplements on Growth and Educational Achievement of Schoolchildren in Bangladesh - Tabular...
Manganese sulphate 0.38 mg, copper sulphate 0.509 mg, zinc sulphate 15 mg ... Manganese sulphate 0.38 mg, copper sulphate 0.509 mg, zinc sulphate 15 mg ...
https://clinicaltrials.gov/ct2/show/record/NCT00859911
*  The Effects of a Polyphenol-enriched Fruit Drink on Metabolic Health - Full Text View - ClinicalTrials.gov
... manganese, phosphorus, potassium and zinc. Subjects already taking vitamin or minerals at a dose around 100 % or less up to 200 ...
https://clinicaltrials.gov/ct2/show/NCT01706653
*  Human Biomarkers for Assessing Copper Deficiency - Full Text View - ClinicalTrials.gov
Drug Information available for: Sodium gluconate Manganese gluconate U.S. FDA Resources ...
https://clinicaltrials.gov/show/NCT01177579
*  Iron & Alginate Study - Full Text View - ClinicalTrials.gov
Drug Information available for: Ferrous gluconate Sodium gluconate Manganese gluconate Iron, elemental ...
https://clinicaltrials.gov/ct2/show/NCT01528644?recr=Open&intr=dietary+calcium&rank=5
*  Comparison Between Effects of Two Iron Preparations on Protein in the Urine - Full Text View - ClinicalTrials.gov
Drug Information available for: Sucrose Sodium gluconate Manganese gluconate Iron, elemental Sodium ferric gluconate complex ...
https://clinicaltrials.gov/ct2/show/NCT00534144
*  A Study of Chlorhexidine in the Prevention of HIV-1 Transmission From Mothers to Their Babies - Full Text View - ClinicalTrials...
Drug Information available for: Chlorhexidine Chlorhexidine acetate Sodium gluconate Chlorhexidine hydrochloride Manganese ...
https://clinicaltrials.gov/ct2/show/NCT00006075
*  Study of 2% Chlorhexidine Gluconate-Impregnated Bath Cloths to Prevent MRSA Colonization in Complex Continuing Care - Full Text...
Drug Information available for: Chlorhexidine Chlorhexidine acetate Sodium gluconate Chlorhexidine hydrochloride Manganese ...
https://clinicaltrials.gov/ct2/show/NCT01717690
*  Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant...
Drug Information available for: Chlorhexidine Chlorhexidine acetate Sodium gluconate Chlorhexidine hydrochloride Manganese ...
https://clinicaltrials.gov/ct2/show/NCT00779246